CD1D and neoplasm: The predominant anti-tumor feature of iNKT cells mainly resides in their capacity to release large amounts of Th1 cytokines, such as IFN-γ, in addition to their ability to kill CD1d-positive tumor cells (99, 100) (Table 1).